Literature DB >> 8341498

Toxoplasmosis neuroretinitis.

R H Fish1, J C Hoskins, L B Kline.   

Abstract

BACKGROUND: Neuroretinitis is a distinct clinical entity consisting of moderate to severe visual loss, optic nerve head edema, macular exudate in a stellate pattern, and variable vitreous inflammation. Although the etiology is usually postviral or idiopathic, an acute infectious cause occasionally is demonstrated.
METHODS: Five juvenile or young adult patients with neuroretinitis are presented with serologic evidence of Toxoplasma gondii infection. Four of the five patients were treated with systemic antibiotics and corticosteroids; one patient was not treated.
RESULTS: With a mean follow-up period of 50 months, visual acuity returned to 20/25 or better in four patients, with one patient regaining visual acuity of 20/60. Two patients had one or more recurrent episodes of neuroretinitis, distinguishing toxoplasmosis from idiopathic neuroretinitis, which is usually a monophasic illness.
CONCLUSION: Toxoplasmosis infection is a rare, but potentially treatable, form of neuroretinitis and should be included in the differential diagnosis of "Leber's idiopathic stellate retinopathy."

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8341498     DOI: 10.1016/s0161-6420(13)31511-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  8 in total

1.  Retinal vascular involvement in acute toxoplasmic retinochoroiditis.

Authors:  P Theodossiadis; S Kokolakis; I Ladas; A C Kollia; D Chatzoulis; G Theodossiadis
Journal:  Int Ophthalmol       Date:  1995       Impact factor: 2.031

Review 2.  Ocular toxoplasmosis II: clinical features, pathology and management.

Authors:  Nicholas J Butler; João M Furtado; Kevin L Winthrop; Justine R Smith
Journal:  Clin Exp Ophthalmol       Date:  2012-09-17       Impact factor: 4.207

3.  Toxoplasma gondii: an atypical presentation of toxoplasma as optic disc swelling and hemispherical retinal vein occlusion treated with intravitreal clindamycin.

Authors:  Roger Wong; Roberto dell'Omo; Michele Marino; Badrul Hussein; Narciss Okhravi; Carlos E Pavesio
Journal:  Int Ophthalmol       Date:  2008-02-23       Impact factor: 2.031

4.  The absence of vitreous inflammation: one more challenge in diagnosing toxoplasma papillitis.

Authors:  Michael Adly Mikhail; Mohan Varikkara
Journal:  BMJ Case Rep       Date:  2013-04-09

Review 5.  Infectious optic neuropathies: a clinical update.

Authors:  Rim Kahloun; Nesrine Abroug; Imen Ksiaa; Anis Mahmoud; Hatem Zeghidi; Sonia Zaouali; Moncef Khairallah
Journal:  Eye Brain       Date:  2015-09-28

Review 6.  [Ocular toxoplasmosis].

Authors:  U Pleyer; N Torun; O Liesenfeld
Journal:  Ophthalmologe       Date:  2007-07       Impact factor: 1.174

7.  Neuroretinitis with dual infections.

Authors:  Kwong-Han Kiu; Hashim Hanizasurana; Embong Zunaina
Journal:  Int Med Case Rep J       Date:  2015-10-19

Review 8.  Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches.

Authors:  Dimitrios Kalogeropoulos; Hercules Sakkas; Bashar Mohammed; Georgios Vartholomatos; Konstantinos Malamos; Sreekanth Sreekantam; Panagiotis Kanavaros; Chris Kalogeropoulos
Journal:  Int Ophthalmol       Date:  2021-08-09       Impact factor: 2.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.